• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Zinc metabolism in patients treated with captopril versus enalapril.

作者信息

Golik A, Modai D, Averbukh Z, Sheffy M, Shamis A, Cohen N, Shaked U, Dolev E

机构信息

Department of Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel.

出版信息

Metabolism. 1990 Jul;39(7):665-7. doi: 10.1016/0026-0495(90)90098-w.

DOI:10.1016/0026-0495(90)90098-w
PMID:2195291
Abstract

Several zinc parameters were assessed in 13 patients with essential hypertension who were chronically taking only captopril (six subjects) or enalapril (seven subjects), as well as in six untreated hypertensives, and nine healthy controls. Serum zinc levels were comparable in all groups. Twenty-four-hour urinary zinc excretion was significantly increased in the captopril-treated patients compared with the other three groups. The zinc:creatinine ratio in 24-hour urine was significantly increased in both captopril and enalapril groups, but was significantly greater in the former. Although plasma zinc concentrations were comparable in all groups, red blood cell (RBC) zinc values were significantly decreased in the captopril group compared with the other three groups. We conclude that (1) although both captopril and enalapril produce renal zinc loss, this loss is far greater in patients receiving captopril; and (2) captopril administration over 3 months or more generates RBC zinc depletion.

摘要

相似文献

1
Zinc metabolism in patients treated with captopril versus enalapril.
Metabolism. 1990 Jul;39(7):665-7. doi: 10.1016/0026-0495(90)90098-w.
2
Effects of captopril and enalapril on zinc metabolism in hypertensive patients.卡托普利和依那普利对高血压患者锌代谢的影响。
J Am Coll Nutr. 1998 Feb;17(1):75-8. doi: 10.1080/07315724.1998.10720459.
3
Effect of diuretics on captopril-induced urinary zinc excretion.利尿剂对卡托普利所致尿锌排泄的影响。
Eur J Clin Pharmacol. 1990;38(4):359-61. doi: 10.1007/BF00315575.
4
Double-blind comparison of captopril and enalapril in mild to moderate hypertension.卡托普利与依那普利治疗轻至中度高血压的双盲比较
J Am Coll Cardiol. 1986 Mar;7(3):651-60. doi: 10.1016/s0735-1097(86)80477-6.
5
[Captopril and enalapril in the treatment of renal hypertension].
Srp Arh Celok Lek. 1990 Jul-Aug;118(7-8):285-90.
6
Mortality associated with captopril and enalapril: a report from the DHSS Hypertension Care Computing Project.卡托普利和依那普利相关的死亡率:来自卫生与社会保障部高血压护理计算机项目的报告。
J Hypertens. 1990 Jun;8(6):521-4. doi: 10.1097/00004872-199006000-00004.
7
Changes in red blood cell glutathione and glutathione-dependent enzymes on long-term treatment with captopril and enalapril.
Clin Chim Acta. 1995 Aug 31;240(1):89-94. doi: 10.1016/0009-8981(95)06121-3.
8
Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.依那普利与卡托普利对比:原发性高血压的双盲多中心比较
Int J Clin Pharmacol Res. 1988;8(3):181-8.
9
Renal failure due to enalapril and captopril in bilateral renal artery stenosis: greater awareness needed.双侧肾动脉狭窄患者使用依那普利和卡托普利导致肾衰竭:需提高认识。
Med J Aust. 1988 May 16;148(10):525-7. doi: 10.5694/j.1326-5377.1988.tb99465.x.
10
Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension.依那普利与卡托普利对轻度高血压患者钾稳态影响的交叉比较
Int J Clin Pharmacol Ther. 1994 Dec;32(12):655-9.

引用本文的文献

1
Zinc as nutritional intervention and prevention measure for COVID-19 disease.锌作为新冠疾病的营养干预和预防措施。
BMJ Nutr Prev Health. 2020 Jun 17;3(1):111-117. doi: 10.1136/bmjnph-2020-000095. eCollection 2020.
2
Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial.利尿剂、钙拮抗剂和血管紧张素转换酶抑制剂对单药治疗的高血压患者的锌状态的影响:一项随机试验。
Nutrients. 2018 Sep 11;10(9):1284. doi: 10.3390/nu10091284.
3
Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.
常用处方药长期使用导致药物-营养相互作用的证据:最新进展
Pharmaceutics. 2018 Mar 20;10(1):36. doi: 10.3390/pharmaceutics10010036.
4
Zinc and the prooxidant heart failure phenotype.锌与促氧化心力衰竭表型
J Cardiovasc Pharmacol. 2014 Oct;64(4):393-400. doi: 10.1097/FJC.0000000000000125.
5
Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.盐皮质激素受体拮抗作用可在心力衰竭中发挥心脏保护作用。
Curr Heart Fail Rep. 2013 Mar;10(1):36-45. doi: 10.1007/s11897-012-0120-x.
6
Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.钙代谢紊乱和心肌细胞坏死:钙调节激素的作用。
Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):77-86. doi: 10.1016/j.pcad.2012.02.004.
7
Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.通过以线粒体为中心的信号转导-效应器途径,心肌细胞坏死过程中的细胞内钙超载和氧化应激。
Exp Clin Cardiol. 2011 Winter;16(4):109-15.
8
Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.阳离子失衡与心肌细胞坏死:再探弗莱肯斯坦假说。
Eur Heart J. 2011 Aug;32(15):1846-53. doi: 10.1093/eurheartj/ehr063. Epub 2011 Mar 12.
9
Congestive heart failure: where homeostasis begets dyshomeostasis.充血性心力衰竭:内稳态如何导致失调。
J Cardiovasc Pharmacol. 2010 Sep;56(3):320-8. doi: 10.1097/FJC.0b013e3181ed064f.
10
Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.心肌坏死和替代纤维化的细胞和分子途径。
Heart Fail Rev. 2011 Jan;16(1):23-34. doi: 10.1007/s10741-010-9169-3.